AbbVie is a global biopharmaceutical company formed in 2013 when it was spun off from Abbott Laboratories. The company focuses on developing advanced therapies for complex diseases, particularly in areas such as immunology, oncology, and neuroscience. AbbVie is known for its flagship product, Humira, which is used to treat various autoimmune conditions. The company invests heavily in research and development to create innovative treatments. AbbVie operates in more than 75 countries and collaborates with various organizations to enhance its drug discovery and development processes. Its commitment to improving patient outcomes drives its mission in the healthcare industry.